Table 3.
Number of overlap | Cardiac | Coronary | Glom | Motor | mTAL | NTS | PBC | PCT | Raphe |
---|---|---|---|---|---|---|---|---|---|
Known miRNAs | |||||||||
Cardiac | 172 | 128 | 141 | 124 | 135 | 124 | 134 | 126 | 122 |
Coronary | 143 | 130 | 117 | 122 | 112 | 122 | 119 | 116 | |
Glom | 214 | 132 | 160 | 137 | 145 | 146 | 134 | ||
Motor | 191 | 121 | 158 | 169 | 120 | 155 | |||
mTAL | 183 | 126 | 132 | 143 | 122 | ||||
NTS | 194 | 169 | 120 | 152 | |||||
PBC | 202 | 128 | 160 | ||||||
PCT | 165 | 119 | |||||||
Raphe | 183 | ||||||||
Newly identified miRNAs | |||||||||
Cardiac | 148 | 89 | 94 | 80 | 81 | 83 | 88 | 92 | 83 |
Coronary | 115 | 90 | 82 | 81 | 81 | 87 | 85 | 86 | |
Glom | 145 | 82 | 89 | 81 | 91 | 100 | 90 | ||
Motor | 122 | 71 | 90 | 88 | 86 | 91 | |||
mTAL | 103 | 73 | 82 | 87 | 77 | ||||
NTS | 114 | 91 | 80 | 91 | |||||
PBC | 124 | 86 | 89 | ||||||
PCT | 118 | 87 | |||||||
Raphe | 122 | ||||||||
% of overlap, known/new miRNAs | |||||||||
Cardiac | 1.00 | 1.20 | 1.14 | 1.15 | 1.18 | 1.07 | 1.11 | 1.08 | 1.12 |
Coronary | 1.00 | 1.05 | 1.01 | 1.01 | 0.94 | 0.97 | 1.06 | 0.98 | |
Glom | 1.00 | 1.06 | 1.12 | 1.07 | 1.03 | 1.01 | 1.00 | ||
Motor | 1.00 | 1.03 | 1.08 | 1.20 | 0.94 | 1.11 | |||
mTAL | 1.00 | 0.99 | 0.95 | 1.04 | 0.97 | ||||
NTS | 1.00 | 1.12 | 0.97 | 1.05 | |||||
PBC | 1.00 | 0.98 | 1.15 | ||||||
PCT | 1.00 | 0.94 | |||||||
Raphe | 1.00 |
See Table 1 for abbreviations. The known/new microRNA (miRNA) ratio for % overlap was calculated as [kC1/2/(kC1 + kC2)]/[nC1/2/(nC1 + nC2)], in which k refers to known miRNAs, n refers to new miRNAs, and C1, C2, and C1/2 refer to the number of miRNAs detected in tissue region 1, 2, and both 1 and 2, respectively. Ratios >1 are shown in italics.